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Haploidentical hematopoietic stem cell transplantation (HSCT) constitutes an important alternative for
patients lacking a human leukocyte antigen (HLA)-matched donor. Although the use of haploidentical donors
is increasingly common, the long-term impact of generating a donor-derived immune system in the context
of an HLA-mismatched thymic environment remains poorly characterized. We performed an in-depth
assessment of immune reconstitution in a group of haploidentical HSCT recipients 4 to 6 years
posttransplantation, in parallel with the respective parental donors and age-matched healthy control
subjects. Our data show that the proportion of naive and memory subsets in the recipients, both within CD8þ
and CD4þ T cells, more closely resembled that observed in age-matched control subjects than in the donors.
HSCT recipients displayed relatively high signal-joint T cellereceptor excision circle levels and a high
frequency of the recent thymic emigranteenriched CD31þ subset within naive CD4þ and naive regulatory T
cells. Moreover, CD8þ, CD4þ, and regulatory T cells from HSCT recipients displayed a diverse T cell repertoire.
These results support a key role for thymic output in T cell reconstitution. Nevertheless, HSCT recipients had
signiﬁcantly shorter telomeres within a naive-enriched CD4þ T cell population than age-matched control
subjects, despite the similar telomere length observed within the most differentiated CD8þ and CD4þ T cell
subsets. Overall, our data suggest that long-term immune reconstitution was successfully achieved after
haploidentical HSCT, a process that appears to have largely relied on de novo T cell production.
 2013 American Society for Blood and Marrow Transplantation.INTRODUCTION
Allogeneic hematopoietic stem cell transplantation
(HSCT) has been increasingly performed in patients with
severe hematologic and immunologic diseases [1]. Because
most patients lack a human leukocyte antigen (HLA)-
matched sibling, the use of volunteer unrelated donors is
a common alternative [2]. The search for an unrelated HLA-
matched donor is, however, a lengthy process, with vari-
able success (10% to 70%) depending on patient ethnicity [3].
Haploidentical related donors (ie, ﬁrst-degree relatives
sharing 1 haplotype with the patient while being variably
mismatched for the other HLA alleles) represent a good
alternative for patients lacking an HLA-matched donor [2].
The advantages of haploidentical donors are their prompt
availability for most patients and a potentially enhanced
graft-versus-tumor effect [2,4]. Moreover, when several
haploidentical donors are available, the most suitable donor
can be chosen according to age, cytomegalovirus status, and
donor-versus-recipient natural killer cell alloreactivity [5,6].
On the other hand, haploidentical HSCT has attendant risks
associated with crossing the HLA barrier, namely graft
failure, severe graft-versus-host disease (GVHD), and delayed
immune reconstitution.dgments on page 711.
equests: Maria V.D. Soares, Unidade de
edicina Molecular, Av. Prof. Egas Moniz,
.pt (M.V.D. Soares).
2013 American Society for Blood and Marrow
13.01.017The outcome of haploidentical HSCT has improved
signiﬁcantly over the past 2 decades due to developments
in conditioning regimens, graft engineering, and
posttransplantation immune suppression. Reduced-intensity
conditioning regimens have helped circumvent myeloa-
blative regimenerelated toxicity and mortality [4,7]. Graft
failure and severe GVHD have been partly surmounted
through the use of extensively T celledepleted grafts [8-10],
which leads to the generation of a donor-derived immune
systemwherein thymic Tcell selection takes place in an HLA-
mismatched environment [11]. We and others have shown
that the infusion of puriﬁed CD34þ cells provides sufﬁcient
T and B cell depletion for haploidentical HSCT from related
donors [10,12]. Unfortunately, this approach is still associated
with delayed immune reconstitution and consequently also
with substantial rates of infection-related mortality and
leukemia relapse [13].
Although haploidentical HSCT is increasingly performed
in patients who lack an HLA-matched donor, few studies
have characterized immune reconstitution after this type of
transplantation [7], particularly the long-term impact on the
composition of naive and memory T cell pools. In the present
study, we performed a detailed evaluation of the long-term
immune reconstitution achieved by patients with acute
myeloid leukemia or aplastic anemia who underwent hap-
loidentical related HSCT after a chemotherapy-alone condi-
tioning regimen [12]. These patients were, at the time of the
study, 4 to 6 years posttransplantation and were analyzed in
parallel with their respective donors, who were always 1 ofTransplantation.
R.I. Azevedo et al. / Biol Blood Marrow Transplant 19 (2013) 703e712704the parents, and age-matched healthy control subjects. We
were particularly interested in investigating the relative
contribution of thymic output and peripheral expansion of
mature T cells to the process of T cell reconstitution in these
patients.METHODS
Patients and Sample Collection
A cross-sectional study was performed involving 5 haploidentical
related HSCT recipients, 4 to 6 years posttransplantation. During a 62-month
period, 15 patients (11 with acute myeloid leukemia, 3 with chronic myeloid
leukemia, and 1 with aplastic anemia) were treated with an allogeneic stem
cell transplantation from a fully haploidentical donor, because a related or
unrelated HLA-matched donor was unavailable [12,14].
The conditioning regimen consisted of thiotepa 5 mg/kg/d on days 9
and 8, ﬂudarabine 40 mg/m2/d on days 9 to 5, rabbit antithymocyte
globulin 5mg/kg/d on days7 to3 as a 12- to 24-hour infusion, melphalan
60 mg/m2/d on days 4 and 3, cyclosporine 3 mg/kg/d on days 10 to 2,
and prednisolone 2 mg/kg/d on days 7 to 3 [12,14]. The 14 high-
risk leukemia patients received a median of 5.4  106 (range, 2.9 to
13.8  106) CD34þ cells/kg, 1.62  104 (range, .33 to 5.96  104) CD3þ cells/
kg, and 9.32104 (range, 5.5 to 12.55104) CD19þ cells/kg [12]. The patient
with aplastic anemia received a total of 8.66  106 CD34þ cells/kg, 1.17  104
CD3þ cells/kg, and 11.3  104 CD19þ cells/kg [14]. T cell depletion was the
only GVHD prophylaxis [12,14].
All patients received at least 1 infusion of donor whole blood containing
5, 7, 10, 25, or 50  103 CD3þ cells/kg between days 25 and 95 after trans-
plantation [12,14]. Four to 6 years posttransplantation, we studied 5 of the 6
surviving members of this patient group. These patients, who comprised 3
men and 2womenwith amedian age of 30 years (range, 24 to 34), had poor-
prognosis acute myeloid leukemia (n ¼ 4) or aplastic anemia (n ¼ 1). The
donors were always 1 of the parents, comprising 4 men and 1 woman with
a median age of 55 years (range, 50 to 62). All donorepatient pairs shared 3/
6 HLA antigens. The age-matched control group comprised 3 men and 2
women with a median age of 31 years (range, 24 to 35).
Peripheral blood mononuclear cells were isolated by Ficoll-Hypaque
density gradient (Amersham Pharmacia Biotech, Uppsala, Sweden) from
heparinized peripheral blood, and serum samples were collected in
parallel. This study was approved by the Ethical Board of the Faculty of
Medicine, University of Lisbon, and all patients gave written informed
consent.Flow Cytometric Analysis
Freshly isolated peripheral blood mononuclear cells (PBMCs) were
resuspended in phosphate-buffered saline (PBS) containing 1% bovine
serum albumin (Sigma-Aldrich) St. Louis, MO and .1% sodium azide (Sigma-
Aldrich) and stained for 20 minutes at room temperature with the following
anti-humanmonoclonal antibodies: CD4 allophycocyaninecyanin 7 (Cy7) or
ﬂuorescein isothiocyanate (FITC; clone RPA-T4, BD Biosciences); CD8 peri-
dinin chlorophyll protein (PerCP-Cy5.5), eFluor 605 (clone RPA-T8,
eBioscience, San Diego, CA) or biotin (clone OKT8, eBioscience); CD45RA
PerCP-Cy5.5, allophycocyanin, or biotin (clone HI100, eBioscience); CD27
FITC, phycoerythrin, or phycoerythrin -Cy7 (clone O323, eBioscience); CD31
allophycocyanin (clone WM59, eBioscience); and Streptavidin Cy3 (Cedar-
lane Laboratories, Ontario, Canada). Intracellular staining for Ki67 FITC
(clone B56, BD Biosciences) and Foxp3 Paciﬁc Blue (clone PCH101, eBio-
science) was performed using ﬁxation and permeabilization reagents from
eBioscience. Samples were acquired on a BD FACSAria ﬂow cytometer (BD
Biosciences) after ﬁxationwith 1% formaldehyde (Sigma-Aldrich). Datawere
analyzed using FlowJo software version 8.1.1 (TreeStar, Ashland, OR).Telomere Length Measurement by Flow CytometryeFluorescent In Situ
Hybridization
Telomere length was measured using a modiﬁed version of the ﬂuo-
rescent in situ hybridization coupled with the ﬂow cytometry protocol
previously described [15,16]. In brief, PBMCs were surface stained for CD4,
CD8, CD45RA, and CD27. After washing in PBS, cells were ﬁxed in 1 mM BS3
(Perbio Science, Northumberland, UK). The reaction was quenched with 50
mM Tris (pH 7.2) in PBS. After washing in PBS followed by hybridization
buffer, cells were incubated in .75 mg/mL protein nucleic acid telomeric
probe (C3TA2)3 conjugated to Cy5 (Panagene, Daejeon, Korea). After being
heated for 10 minutes at 82C, samples were left to hybridize. Samples were
washed in posthybridization buffer followed by PBS and analyzed imme-
diately by ﬂow cytometry. All samples were run in triplicate alongside
cryopreserved PBMCs with known telomere ﬂuorescence to ensure
consistency of results.Signal-Joint T CelleReceptor Excision Circle Quantiﬁcation by Real-Time
Polymerase Chain Reaction
DNA was puriﬁed from 106 PBMCs using DNAzol reagent (Gibco Life
Technologies Carlsbad, California). Signal-joint T cellereceptor excision
circles (sjTRECs) were quantiﬁed by nested real-time polymerase chain
reaction (PCR) using Power SYBR Green PCR Master Mix (Applied Bio-
systems, Life Technologies, Carlsbad, California) and ABI PRISM 7000
Sequence Detection System (Applied Biosystems). Speciﬁc primers and
probes were used for sjTREC, and CD3g was used as a housekeeping gene
for absolute quantiﬁcation of sjTREC levels: sj-out5, 50-CTCTCCTATCTCTGCT
CTGAA-30; sj-out3, 50-ACTCACTTTTCCGAGGCTGA-30; sj-in5, 50-CCTCTGT
CAACAAAGGTGAT-30; sj-in3, 50-GTGCTGGCATCAGAGTGTGT-30; CD3-out5,
50-ACTGACATGGAACAGGGG AAG-30; CD3-out3, 50-CCAGCTCTGAAGTAGGG
AACATAT-30; CD3-in5, 50-GGCTATCATTCTTCTTCAAGGT-30; CD3-in3, 50-CCTCT
CTTCAGCCATTTAA GTA-30; sj-Probe1, 50-AATAAGTTCAGCCCTCCATGTCACAC
Tf-30; sj-Probe2, 50-XTGTTTTCCATCCTGGGGAGTGTTTCAp-30; CD3-Probe1,
50-GGCTGAAGGTTAGGGATACCAATATTCCTGTCTCf-30; CD3-Probe2, 50-XCTAGT
GATGGGCTCTTCC CTTGAGCCCTTCp-30 .
T Cell Receptor Chain Complementarity-Determining Region
3 Spectratyping
TCRVB complementarity-determining region 3 (CDR3) spectratyping
was performed as previously described [17]. Brieﬂy, total RNAwas extracted
from 105 to 106 cells with RNeasy kit (Qiagen, Dusseldorf, Germany) and ﬁrst
strand cDNA synthesized from 1 to 2 mg of RNA with the Superscript III kit
(Invitrogen Life Technologies, Carlsbad, California) using an equivolume
mixture of random hexamers and oligo (dT). Ampliﬁcation of the TCRVB
CDR3 was performed using primers speciﬁc for each Vb family [18], except
for Vb6 and Vb21 [19], and a common CB reverse primer [18]; followed by
a run-off reaction extending each different PCR product with a constant CB
FAM labeled primer [18]; and a third step, in which each different Vb PCR-
labeled fragment was separated on a capillary electrophoresisebased DNA
automated sequencer. Data were collected and analyzed with GeneMapper
v4.0 (Applied Biosystems) for size and ﬂuorescence intensity determination.
Determination of Vb Family Usage by Flow Cytometry
TCR Vb family frequency was quantiﬁed in whole blood using IOTest
Beta Mark (Beckman Coulter, Brea, California), according to the manufac-
turer’s instructions. Samples were labeled with T cell receptor variable beta
chain (TCR Vb)-speciﬁc antibodies conjugated to FITC, phycoerythrin, or
both, together with antibodies against CD4, CD8, and CD27. Fixed/per-
meabilized cells were then stained with anti-human Foxp3 and analyzed by
ﬂow cytometry. The frequency of the individual TCR Vb families was
assessed within T cell populations of interest.
Statistical Analysis
Statistical analysis was performed using GraphPad Prism version 4.00
(GraphPad Software, San Diego, CA). Data are presented as mean with
standard error of mean. Gaussian distribution was conﬁrmed with the
Kolmogorov-Smirnov normality test, and statistical analysis was performed
using a paired or unpaired t-test, as appropriate. P values <.05 were
considered signiﬁcant.
RESULTS
Proportion of Naive and Memory CD4þ and CD8þ T Cell
Subsets
We ﬁrst evaluated the degree of immune reconstitution
achieved 4 to 6 years posttransplantation in recipients of
fully haploidentical HSCT by assessing the absolute numbers
of the main lymphocyte populations in peripheral blood
(Table 1). A trend was observed for HSCT recipients who had
higher numbers of total lymphocytes, total CD3þ T cells,
CD8þ T cells, and natural killer cells, which were identiﬁed
as CD3 cells expressing CD16 and/or CD56, than both
donors and age-matched control subjects, although these
differences did not reach statistical signiﬁcance (Table 1).
Similarly, the absolute numbers of CD19þ B cells tended to
be higher in HSCT recipients than the other 2 groups,
reaching statistical signiﬁcance in comparison with age-
matched control subjects (Table 1). The observed similari-
ties in the absolute numbers of the major lymphocyte
subsets in haploidentical HSCT recipients and age-matched
control subjects were indicative of successful recovery of
the size of these peripheral lymphocyte pools. Additionally,
Table 1
Absolute Counts of the Main Lymphocyte Populations
Donors Recipients Control Subjects
Absolute counts per mL
Lymphocytes 3979  470 5187  896 3809  460
Total T cells 2686  358 2872  480 2401  341
CD8þ T cells 486  97 851  266 615  127
CD4þ T cells 1976  247 1635  180 1616  275
B cells 224  91 417  126* 241  80
NK cells 52  26 118  62 85  42
CD4/CD8 4.45  .59 2.32  .34 2.96  .72
* P ¼ .0399, recipients versus control subjects.
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as well as antigen-speciﬁc stimuli (data not shown),
attesting to the degree of functional competence achieved
by HSCT recipients.
To investigate whether T cell reconstitution was associ-
ated with imbalances in naive and memory T cell subset
distribution, we determined the frequency of naive and
memory subsets, deﬁned by the expression of CD45RA
and CD27, within CD8þ and CD4þ T lymphocytes: CD45RAþ
CD27þ naive, CD45RACD27þ central memory, CD45RAFigure 1. Frequency of naive and memory subsets within the CD8þ and CD4þ T cell po
memory (CM; CD45RACD27þ), effector memory (EM; CD45RACD27), and CD45RA
and CD4þ (B) T lymphocytes in HSCT recipients, donors, and age-matched control sub
Flow cytometry images from a representative recipient, the respective donor, and agCD27 effector memory, and CD45RAþCD27 effector
memory re-expressing CD45RA (EMRA) cells [20] (Figure 1).
HSCT recipients had a signiﬁcantly higher frequency of
CD45RAþCD27þ naive cells and a signiﬁcantly lower
percentage of CD45RAþCD27 EMRA cells within CD8þ
T lymphocytes as compared with donors (paired t-test:
P ¼ .0249 and P ¼ .0116, respectively) (Figure 1A). These
differences were less striking within the CD4þ T cell pop-
ulation, with the 3 groups featuring similar frequencies of
CD45RAþCD27þ naive cells (Figure 1B). Nevertheless, we
also observed a tendency for the recipients to have a lower
proportion of highly differentiated CD45RACD27 effector
memory and CD45RAþCD27 EMRA subsets within the
CD4þ T cell population than the donors (Figure 1B). The
levels of naive T cells have been shown to decrease, whereas
highly differentiated memory T cells increase during aging
[21-23]. Thus, the distinct differentiation proﬁles observed
in recipients and donors may be due to the age difference
between these 2 groups, given that the donors were always
1 of the parents. Nonetheless, recipients tended to have
a less differentiated proﬁle than age-matched control
subjects, particularly within CD8þ T cells (Figure 1A), sug-
gesting that age is not the sole factor contributing to theseols after haploidentical HSCT. The frequency of naive (CD45RAþCD27þ), central
þ EM (EMRA; CD45RAþCD27) cell subsets was determined within CD8þ (A)
jects (*P < .05 between recipients and donors or control subjects and donors).
e-matched control subject are shown.
Figure 2. Assessment of CD31 expression, sjTREC content, and telomere length after haploidentical HSCT. (A) CD31 expression was used to identify a population
enriched in RTEs within naive (CD45RAþCD27þ) CD4þ T lymphocytes. Flow cytometry images from a representative recipient, the respective donor, and age-matched
control subject are shown. (B) Levels of sjTRECs within PBMCs. Results are expressed as the copy number of sjTRECs per 106 PBMCs. (C) Telomere length measured
within CD8þCD27þ and CD27, as well as within CD4þCD45RAþ and CD45RA T lymphocytes. Each symbol represents an individual. Mean values are shown as
horizontal lines. *P < .05.
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immune reconstitution 4 to 6 years posttransplantation,
with evidence of successful recovery and maintenance of
the naive T cell pool.
Mechanisms Underlying the Reconstitution of the Naive
T Cell Pool
We next sought to assess the relative contribution of
thymic output and peripheral expansion to T cell reconsti-
tution in these patients. Several studies used CD31
expression within naive CD4þ T cells to indirectly assess
thymic output after HSCT [24,25]. Although CD31 expres-
sion cannot be considered an absolute marker of recent
thymic emigrants (RTEs), because CD31þ naive CD4þ T cells
are able to undergo interleukin (IL)-7edriven homeostatic
proliferation without losing CD31 expression [26], it iden-
tiﬁes the population that is most enriched in newly gener-
ated T cells as estimated by the quantiﬁcation of sjTREC
[27,28].
To evaluate the relative contribution of thymic output
and peripheral expansion to T cell reconstitution, we ﬁrst
assessed the expression of CD31 within naive CD4þ T cells
(Figure 2A). We observed that the proportion of CD31-
expressing cells within naive CD45RAþCD27þ CD4þ T cells
was signiﬁcantly higher in recipients than in donors (paired
t-test: P ¼ .0135) and similar to that observed in age-matched control subjects (Figure 2A). We further assessed
the contribution of thymic output to immune reconstitution
in recipients via the quantiﬁcation of sjTREC levels in PBMCs
(Figure 2B). At a cell population level, sjTREC content
reﬂects the overall outcome of the TREC-enriching contri-
bution of thymic output and the TREC-diluting effect of
peripheral expansion [29]. In agreement with the high
proportion of CD31þ naive CD4þ T cells, sjTREC levels in
recipients tended to be higher than donors, which were
similar to those observed in age-matched control subjects
(Figure 2B). The observation that the recipients had rela-
tively high sjTREC content suggested that long-term T cell
reconstitution and maintenance did not rely heavily on
peripheral expansion but rather on a substantial contribu-
tion of thymic output.
The replicative history of a cell population may be esti-
mated by the assessment of telomere length. Thus, to
further assess the impact of peripheral expansion on T cell
reconstitution, we evaluated telomere length in CD8þ and
CD4þ T cell subsets (Figure 2C). Naive CD4þ T cells are
known to have longer telomeres than their memory coun-
terparts [30,31]. In agreement, we observed higher
telomere-speciﬁc ﬂuorescence intensity in the naive T cell
subset than in CD4þ T cells lacking CD45RA expression in all
3 groups (paired t-test: donors, P ¼ .0125; recipients,
P ¼ .0364; control subjects, P ¼ .0004). As shown in
R.I. Azevedo et al. / Biol Blood Marrow Transplant 19 (2013) 703e712 707Figure 2C, when telomere length within CD45RAþ or
CD45RA CD4þ T cells was compared among the 3 groups,
recipients tended to have longer telomeres than the
respective donors but had signiﬁcantly shorter telomeres
within CD4þCD45RAþ cells as compared with age-matched
control subjects (paired t-test: P ¼ .0316). The latter had
signiﬁcantly longer telomeres within both CD4þCD45RAþ
and CD4þCD45RA subsets than donors (unpaired t-test:
P ¼ .0220 and P ¼ .0386, respectively). The observation that
telomere length within the naive-enriched CD45RAþ CD4þ
T cell subset was signiﬁcantly shorter in recipients than in
age-matched control subjects may suggest that peripheral
expansion may also have contributed to T cell recovery in
these individuals. Additionally, it may reﬂect the inherently
shorter telomeres of CD34þ hematopoietic stem cells from
the parental donors.
For the measurement of telomere length within CD8þ
T cells, CD8 was costained with CD27, as we could only use 2
surface markers. CD27 was selected because it allows the
discrimination between a CD27þ population comprising
CD45RAþCD27þ naive and CD45RACD27þ central memory
CD8þ T cells and a CD27 population containing highly
differentiated CD45RACD27 effector memory and
CD45RAþCD27 EMRA CD8þ T cells (Figure 2C). As expected,
CD27þ CD8þ T cells had signiﬁcantly longer telomeres than
their CD27 counterparts in all 3 groups (paired t-test:
donors, P ¼ .002; recipients, P ¼ .0173; control subjects,
P ¼ .0018). Similar to the results obtained for CD4þ T cell
subsets, recipients tended to have longer telomeres than the
respective donors (Figure 2C).
Overall, our data support a major contribution of the
thymus to the replenishment of the T cell compartment.
However, peripheral expansion of naive T cells was also likely
to play a role.
T Cell Receptor Repertoire of the CD4þ and CD8þ T Cell
Pools
Next, we assessed whether the restoration of T cell
numbers was accompanied by the establishment of a
diverse T cell receptor repertoire. For this purpose, we
performed a spectratyping analysis in puriﬁed CD4þ and
CD8þ T cells (Figure 3A, B). This analysis provides a measure
of diversity at the level of CDR3 length, reﬂecting the overall
sequence heterogeneity. T cell pools with a diverse poly-
clonal T cell receptor repertoire present a Gaussian distri-
bution of CDR3 length, whereas skewed T cell receptor
repertoires have a CDR3 length distribution with a reduced
number of peaks or may even comprise a single peak, in the
case of clonal dominance [32,33]. Figure 3A illustrates
representative spectratypes of CD8þ T cells from a trans-
plantation recipient together with the respective donor and
age-matched control subject. The CD8 TCRVB repertoire was
largely polyclonal in all recipients, although CD8þ T cells
from 1 individual displayed a monoclonal distribution
within the Vb9 and Vb11 families, whereas another had
a monoclonal distribution within the Vb22 family (data not
shown).
As for the CD4þ T cell pool, all recipients displayed
a polyclonal distribution of CDR3 length, except for 1 indi-
vidual who had an oligoclonal distribution of the Vb13 and
Vb22 families (data not shown). This markedly polyclonal
spectratype proﬁle closely resembled that observed in CD4þ
T cells from age-matched control subjects, as illustrated by
the representative individuals shown in Figure 3B. As
previously described [34,35], we observed moreperturbations in TCRVB repertoire diversity in CD8þ T cells
(Figure 3A) than in CD4þ T cells (Figure 3B). This may be due
to the more robust and prolonged proliferative response
upon antigen encounter observed in CD8þ compared with
CD4þ T cells [35].
We also performed a spectratyping analysis within gd
T cells (data not shown). All patients showed a Gaussian
polyclonal distribution of these 2 major Vd subsets, whereas
the donor and age-matched control groups displayed a more
restricted clonal proﬁle of the Vd1 and Vd2 families (data not
shown). As for the main Vg families, all 3 groups showed
a predominantly polyclonal proﬁle (data not shown). When
we compared the distribution of the different Vd and Vg
among the 3 groups, the only statistically signiﬁcant differ-
ence observed was in the frequency of Vd4 expression
between recipients and donors (recipients, 18.39  5.33;
donors, 2.09  1.06; paired t-test: P ¼ .0474). The frequency
of Vd4 expression in the age-matched control subjects was
intermediate compared with the other 2 groups (10.95 
4.61).
We further analyzed the TCR Vb family usage within
naive CD8þ (Figure 3C) and CD4þ (Figure 3D) T cells. We
used the IOTest b Mark kit (Beckman Coulter), a ﬂow
cytometryebased assay for quantitative analysis of the TCR
Vb repertoire, which assesses the frequency of 24 Vb families
covering z70% of the T cell receptor repertoire of human
T lymphocytes. The results of the TCR Vb distribution anal-
ysis for the CD45RAþCD27þ naive CD8þ subset are shown in
Figure 3C and those for the RTE-enriched CD31þ naive CD4þ
T cell subset in Figure 3D, illustrating the diverse set of TCR
Vb family usage. Interestingly, the Vb2, Vb5.1, Vb5.3, and
Vb17 families were overrepresented in CD31þ naive CD4þ
T cells from donors as compared with recipients (Figure 3D),
with the latter displaying an even broader distribution of Vb
family usage. Thus, TCR Vb analysis revealed a largely poly-
clonal repertoire both within the CD4þ and CD8þ T cell
pools, indicating that the immune reconstitution accom-
plished in the recipients was associated with a diverse T cell
repertoire.
Reconstitution of the Regulatory T Cell Pool
A major complication post-HSCT is GVHD, which is
associated with poor regulatory T cell (Treg) reconstitution in
the ﬁrst year posttransplantation [36]. All patients received
a small dose of donor leukocytes posttransplantation
(between 6  103/kg and 5  104/kg CD3þ cells) to improve
engraftment and/or to boost immune recovery [12,14].
Four of 5 patients received these cells until day 72
posttransplantation and developed acute GVHD grades I (n¼
1), II (n¼ 1), III (n¼ 1), and IV (n¼ 1), which was successfully
treated with immunosuppression. None of them developed
chronic GVHD. Wewere thus very interested in assessing the
long-term reconstitution of Tregs in this particular group of
patients submitted to haploidentical HSCT.
The frequency of Tregs within the CD4þ T cell pool was
similar in the 3 groups (Figure 4A). Recipients had Treg levels
comparable with those observed in age-matched control
subjects, both in terms of frequency and of absolute numbers
(recipients, 49  11 counts/mL; control subjects, 44  6
counts/mL). As for the differentiation state of these Tregs, the
proportion of naive cells within the Treg population was also
comparable in all groups (Figure 4B). Interestingly, when we
assessed the frequency of CD31þ cells within the naive Treg
pool, transplantation recipients displayed signiﬁcantly
higher levels of this RTE-enriched population in comparison
Figure 3. TCR Vb repertoire of CD8þ and CD4þ T lymphocytes after haploidentical HSCT. Spectratyping analysis of the CDR3 VB regions of the CD8þ (A) and CD4þ (B)
T cell pools. Spectratypes for each VB family from a representative recipient and the respective donor and age-matched control subject are shown. Flow cytometry
analysis of TCR Vb family usage within naive CD8þ (C) and CD31þ naive CD4þ T cells (D). Bar graphs show mean with standard error of the mean. *P < .05, **P < .01.
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maintenance of the naive Treg compartment in HSCT recip-
ients did not seem to mainly rely on enhanced peripheral
expansion, given that the frequency of cycling cells,
as assessed by Ki67 expression, within CD31þ naive Tregs
(Figure 4D) and the overall naive CD45RAþCD27þ Treg pool
(data not shown) was very low in these individuals. Therewere no statistically signiﬁcant differences in the frequency
of Ki67þ cells within total CD4þFoxp3þ and memory
CD45RA Tregs among the 3 groups (data not shown).
We further assessed the TCR Vb repertoire within the Treg
pool (Figure 4E). The recipient group displayed a balanced
TCR Vb family usage, whereas the frequency of the Vb5.2 and
Vb14 families was signiﬁcantly higher in donors as compared
Figure 4. Analysis of the Treg pool after haploidentical HSCT. (A) Frequency of Tregs (CD4þFoxp3þ) within the CD4þ T cell population. (B) Proportion of naive cells
(CD45RAþCD27þ) within the Treg pool. (C) Proportion of CD31þ cells within naive Tregs. (D) Frequency of cycling CD31þ naive Tregs, identiﬁed by Ki67 expression.
Mean values are shown as horizontal lines. Each symbol represents an individual. (E) Flow cytometry analysis of TCR Vb family usage within Tregs. Bar graph shows
mean with standard error of the mean. *P < .05, **P < .01.
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were only observed within CD45RA but not CD45RAþ Tregs
(data not shown). Overall, HSCT recipients have successfully
reconstituted a diverse Treg pool through a mechanism that
involves de novo thymic production.
DISCUSSION
Haploidentical HSCTconstitutes a particularly challenging
clinical setting because the number of mature T cells in the
graft needs to be minimal to prevent GVHD, leading to
delayed immune reconstitution. Moreover, the conditioning
regimen may damage thymic and/or peripheral lymphoid
tissues, further hindering naive T cell output and memory
Tcell homeostasis. To assess whether immune reconstitution
was successfully achieved after haploidentical HSCT, as well
as the potential mechanisms underlying this recovery, we
performed a cross-sectional study of long-term immune
reconstitution in a group of 5 patients who had received
a CD34þ puriﬁed stem cell graft from full-haplotype mis-
matched related donors. The main limitation of our studywas the small number of HSCT recipients whowere available
for evaluation 4 to 6 years posttransplantation. Nevertheless,
our study group comprised a substantial proportion of the
original cohort of haploidentical HSCT recipients (5 of 15,
33.3%) and of the surviving patient group (5 of 6, 83,33%).
We evaluated T cell reconstitution in these patients by
combining naive/memory T cell phenotyping, sjTREC quan-
tiﬁcation, telomere length measurement, and T cell reper-
toire analysis.
We observed a successful recovery of absolute CD8þ and
CD4þ Tcell counts, aswell as of B andnatural killer cells, in the
transplantation recipients. We further observed that trans-
plantation recipients tended to have increased frequencies of
naive CD45RAþCD27þ cells and lower frequencies of EMRA
CD45RAþCD27 cells than their respective donors,with these
differences reaching statistical signiﬁcance within CD8þ
T cells. The CD45RAþCD27 subset has been described in
humanCD8þTcells as themostdifferentiated typeofmemory
cells, which is supported by their low proliferative capacity,
high susceptibility to apoptosis, and loss of CD28 and CCR7
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shown to accumulate during aging [39] and chronic viral
infections [40,41], comprising large clonal expansions of
virus-speciﬁc cells [41]. As for CD4þ T cells, we previously
demonstrated that CD45RAþCD27 CD4þ T cells are prone to
telomere-independent senescence through a process partly
driven by the p38MAPK pathway [20] and that these cells are
accumulated during chronic cytomegalovirus infection [42],
a setting associated with persistent antigen stimulation.
Hence, the absence of inﬂated CD45RAþCD27 T cell pop-
ulations in these transplantation recipients suggests that
restoration of T cell numbers was not mainly driven by clonal
expansion.
We sought to investigate the relative contribution of
thymic-dependent and -independent mechanisms to the
replenishment of the T cell pool in these patients. Thymic-
independent mechanisms include antigen- and/or
cytokine-driven expansion of mature donor T cells infused
with the graft, resulting in limited T cellereceptor diversity.
Conversely, thymic-dependent mechanisms require de novo
production of naive T cells from donor-derived precursor
cells, generating a more long-lasting and diverse T cell
reconstitution [43]. We found that the frequency of CD31þ
cells, a population enriched in RTEs, was signiﬁcantly higher
in recipients than in donors and similar to that observed in
age-matched control subjects. The absolute numbers, as well
as the frequency, of CD31þ naive CD4þ T cells in human
peripheral blood have been shown to decrease with aging, in
parallel with the decline in TREC content [27,44].
The signiﬁcantly higher frequencies of CD31þ naive CD4þ T
cells observed in the recipients are likely to reﬂect not only the
age gap between the recipients and their parental donors but
also the contribution of de novo naive T cell production to
immune reconstitution. We previously reported that the
CD31þ naive CD4þ T cell subset can be maintained by an
IL-7edriven peripheral expansion [26]. IL-7 levels have been
described as being increased during lymphopenic states,
such as those taking place immediately after stem cell
transplantation [45]. Once normal CD4þ T cell numbers are
restored, particularly within the naïve CD4þ T cell subset, IL-7
has been shown to return to steady state levels [46-48]. At the
time of the study, transplantation recipients did not have
higher IL-7 serum levels than the other 2 groups (data not
shown), which is in agreement with the observation of
comparable CD4þ T cell counts (Table 1), as well as of CD31þ
naive CD4þ T cell frequencies, between recipients and age-
matched control subjects. Moreover, the expression levels
(both in termsof frequencyandmedianﬂuorescence intensity)
of IL-7Ra within naive and memory CD4þ and CD8þ T cells,
particularlywithinCD31þnaiveCD4þTcells,were similar inall
3 groups (datanot shown). Althoughweobserved low levels of
proliferationwithin naive CD4þ Tcells at the time of our study
(<1%Ki67þ cells bothwithin total naive CD45RAþCD27þ CD4þ
T cells and the CD31þ naive subset), IL-7edriven homeostatic
proliferation is likely to have contributed to the replenishment
of the CD31þ naive CD4þ T cell subset in the initial stages of
immune reconstitution, during which the cells would have
been exposed to elevated IL-7 levels.
To further ascertain the contribution of thymic-
dependent and -independent mechanisms to immune
reconstitution, we compared sjTREC levels and telomere
length in our 3 groups. The relatively high sjTREC content
within PBMCs from recipients as compared with age-
matched control subjects supports a contribution of thymic
output to the immune reconstitution. On the other hand,although recipients and age-matched control subjects dis-
played similarly long telomeres within the more differenti-
ated CD4þ and CD8þ T cell subsets, telomere length within
the naive-enriched CD4þCD45RAþ subset in the recipients
was signiﬁcantly shorter than in the age-matched control
subjects, more closely resembling that observed in the
donors. Telomere length in HSCT recipients has been found
to correlate with donor age [49], indicating that hemato-
poietic stem cells harvested from older donors have shorter
telomeres. Although the low levels of telomerase activity
displayed by hematopoietic stem cells are sufﬁcient to
ensure long-term survival, they do not appear to prevent
age-associated telomere erosion in these cells [50]. Hence,
the observation that HSCT recipients tended to have shorter
telomeres than their age-matched control subjects, particu-
larly within naive-enriched subsets, may be a consequence of
infusing CD34þ hematopoietic stem cells from parental
donors. Additionally, as mentioned previously, this may also
be partly due to increased levels of IL-7edriven homeostatic
proliferation of the CD31þ naive CD4þ T cell subset in the
recipients during the initial stages of immune reconstitution.
The presence of a broad and largely polyclonal T cell
repertoire in transplantation recipients, comparable with
that observed in age-matched control subjects, supports the
view that immune reconstitution likely relied on thymic
output together with peripheral T cell proliferation driven by
homeostatic triggers.
The induction and maintenance of immune tolerance
after allogeneic HSCT is of the utmost importance, given that
its loss may lead to major clinical complications, particularly
chronic GVHD, which remains a signiﬁcant cause of
posttransplantation morbidity and mortality [51]. Further-
more, acute and chronic GVHD have been shown to target
thymic function and to be associated with poor immune
reconstitution [52-54]. On the other hand, a sustained
contribution of thymic output to immune reconstitution
might decrease the risk of GVHD throughnegative selection of
self-reactive Tcells during de novoTcell generation [55]. Tregs
have been shown to play a critical role in the establishment of
post-HSCT tolerance in murine studies [56,57]. In humans,
lower levels of Tregs have been associated with a higher risk
of chronic GVHD incidence and severity [36]. A study showed
for the ﬁrst time in humans that early infusion of donor
Tregs, in the absence of pharmacological GVHD prophylaxis,
allows for the administration of signiﬁcant numbers of
conventional CD4þ T cells at the time of haploidentical HSCT,
leading to a faster recovery of posttransplantation immunity
without GVHD [58]. Hence, a timely reconstitution of the Treg
pool appears to be vital for overall immune reconstitution
and tolerance. Although all but 1 of our HSCT recipients
developed acute GVHD after the infusion of a limited dose of
donor leukocytes, none developed chronic GVHD. The
observation that all patients successfully replenished the Treg
compartment is in line with this subset’s ability to control
and prevent chronic GVHD. All recipients had Treg levels
comparable with those observed in age-matched control
subjects, both in terms of frequency and of absolute numbers,
which may have crucially contributed to immune reconsti-
tution and tolerance establishment post-haploidentical HSCT.
Interestingly, the frequency of CD31þ cells within the naive
Treg population was signiﬁcantly higher in the recipients
compared with donors, despite the frequency of cycling cells
within the CD31þ naive Treg subset being lower in the
former, further suggesting a substantial contribution of
thymic output to the replenishment of the T cell pool.
R.I. Azevedo et al. / Biol Blood Marrow Transplant 19 (2013) 703e712 711Overall, our data show that once the initial
posttransplantation period is successfully overcome, full
immune reconstitution can be achieved after haploidentical
HSCT. Our results further suggest that T cell homeostasis was
effectively restored in these patients, a process that appears
to have mostly relied on thymus-dependent mechanisms,
despite the high degree of HLAmismatch between donor and
recipient in this setting.
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